{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:29:47Z","timestamp":1792009787654,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.75003","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T07:03:38Z","timestamp":1733209418000},"source":"Crossref","is-referenced-by-count":1,"title":["Fusobacterium nucleatum-Induced Empyema Masquerading as Lung Cancer: A Diagnostic Challenge"],"prefix":"10.7759","author":[{"given":"Ahmed R","family":"Fadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser N","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150476","article-title":"Lemierre syndrome: early recognition and management","volume":"187","author":"Dalen CT","year":"2015","unstructured":"Dalen CT, Mekhail AM. Lemierre syndrome: early recognition and management. CMAJ. 2015, 187:1229-31. 10.1503\/cmaj.150476","journal-title":"CMAJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad378","article-title":"Pleural empyema caused by Streptococcus intermedius and Fusobacterium nucleatum: a distinct entity of pleural infections","volume":"77","author":"Dyrhovden R","year":"2023","unstructured":"Dyrhovden R, Eagan TM, Fl\u00f8tten \u00d8, et al.. Pleural empyema caused by Streptococcus intermedius and Fusobacterium nucleatum: a distinct entity of pleural infections. Clin Infect Dis. 2023, 77:1361-71. 10.1093\/cid\/ciad378","journal-title":"Clin Infect Dis"},{"key":"ref3","unstructured":"Anaerobic cultures. (2022). https.\/\/ksvdl.org\/resources\/news\/diagnostic_insights\/july2022\/anaerobic-cultures.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2021.08.001","article-title":"Parapneumonic effusion and empyema","volume":"42","author":"Addala DN","year":"2021","unstructured":"Addala DN, Bedawi EO, Rahman NM. Parapneumonic effusion and empyema. Clin Chest Med. 2021, 42:637-47. 10.1016\/j.ccm.2021.08.001","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5348\/100047Z09SC2018CR","article-title":"A case of rapidly progressive empyema caused by Streptococcus anginosus group bacteria in a young male patient","author":"Chiu SW","year":"2018","unstructured":"Chiu SW, Zefirova J. A case of rapidly progressive empyema caused by Streptococcus anginosus group bacteria in a young male patient. Int J Case Rep Images Med. 2018, 10.5348\/100047Z09SC2018CR","journal-title":"Int J Case Rep Images Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00542-2019","article-title":"The microbiology of pleural infection in adults: a systematic review","volume":"54","author":"Hassan M","year":"2019","unstructured":"Hassan M, Cargill T, Harriss E, et al.. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019, 54:1900542. 10.1183\/13993003.00542-2019","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2004.06.001","article-title":"Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study","volume":"10","author":"Boyanova L","year":"2004","unstructured":"Boyanova L, Vladimir Djambazov, Gergova G, et al.. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe. 2004, 10:261-7. 10.1016\/j.anaerobe.2004.06.001","journal-title":"Anaerobe"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0871-x","article-title":"Fusobacterium nucleatum infections: clinical spectrum and bacteriological features of 78 cases","volume":"44","author":"Denes E","year":"2016","unstructured":"Denes E, Barraud O. Fusobacterium nucleatum infections: clinical spectrum and bacteriological features of 78 cases. Infection. 2016, 44:475-81. 10.1007\/s15010-015-0871-x","journal-title":"Infection"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020248","article-title":"Epidemiology and clinical outcomes of Fusobacterium infections: a six-year retrospective study","volume":"60","author":"Khan A","year":"2024","unstructured":"Khan A, Alzghoul H, Khan AA, et al.. Epidemiology and clinical outcomes of Fusobacterium infections: a six-year retrospective study. Medicina (Kaunas). 2024, 60:248. 10.3390\/medicina60020248","journal-title":"Medicina (Kaunas)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2022.2145729","article-title":"Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms","volume":"15","author":"Fan Z","year":"2023","unstructured":"Fan Z, Tang P, Li C, Yang Q, Xu Y, Su C, Li L. Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. J Oral Microbiol. 2023, 15:2145729. 10.1080\/20002297.2022.2145729","journal-title":"J Oral Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5212401","article-title":"Fusobacterium nucleatum pleural empyema in a patient with progressive rheumatoid arthritis and immunosuppression","volume":"2021","author":"Tang W","year":"2021","unstructured":"Tang W, Liu ZY, Abreu C. Fusobacterium nucleatum pleural empyema in a patient with progressive rheumatoid arthritis and immunosuppression. Case Rep Infect Dis. 2021, 2021:5212401. 10.1155\/2021\/5212401","journal-title":"Case Rep Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1099040","article-title":"Empyema caused by Fusobacterium nucleatum with squamous cell carcinoma of the lung: a case report and literature review","volume":"10","author":"Sun Y","year":"2023","unstructured":"Sun Y, Dong H, Zhang N, Zhao P, Qi Y, Yang X, Wang L. Empyema caused by Fusobacterium nucleatum with squamous cell carcinoma of the lung: a case report and literature review. Front Med (Lausanne). 2023, 10:1099040. 10.3389\/fmed.2023.1099040","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113425","article-title":"The intersection between oral microbiota, host gene methylation, and patient outcomes in head and neck squamous cell carcinoma","volume":"12","author":"Chen Z","year":"2020","unstructured":"Chen Z, Wong PY, Ng CW, et al.. The intersection between oral microbiota, host gene methylation, and patient outcomes in head and neck squamous cell carcinoma. Cancers (Basel). 2020, 12:10.3390\/cancers12113425","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2009.08.003","article-title":"Approaches to the study of the systematics of anaerobic, gram-negative, non-sporeforming rods: current status and perspectives","volume":"15","author":"Shah HN","year":"2009","unstructured":"Shah HN, Olsen I, Bernard K, Finegold SM, Gharbia S, Gupta RS. Approaches to the study of the systematics of anaerobic, gram-negative, non-sporeforming rods: current status and perspectives. Anaerobe. 2009, 15:179-94. 10.1016\/j.anaerobe.2009.08.003","journal-title":"Anaerobe"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01550-2018","article-title":"Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial","volume":"54","author":"Luengo-Fernandez R","year":"2019","unstructured":"Luengo-Fernandez R, Penz E, Dobson M, Psallidas I, Nunn AJ, Maskell NA, Rahman NM. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. Eur Respir J. 2019, 54:10.1183\/13993003.01550-2018","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09582-9","article-title":"Management of patient with Fusobacterim nucletum related pleural empyema: intrapleural antibiotic therapy can be considered for salvage therapy","volume":"24","author":"Wang J","year":"2024","unstructured":"Wang J, Li J, Sun Z, et al.. Management of patient with Fusobacterim nucletum related pleural empyema: intrapleural antibiotic therapy can be considered for salvage therapy. BMC Infect Dis. 2024, 24:675. 10.1186\/s12879-024-09582-9","journal-title":"BMC Infect Dis"},{"key":"ref17","article-title":"Trapped Lung","author":"Upadrista PK","year":"2024","unstructured":"Upadrista PK, Sabbula BR, Akella J. Trapped Lung. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2024."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/322598-fusobacterium-nucleatum-induced-empyema-masquerading-as-lung-cancer-a-diagnostic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T07:03:42Z","timestamp":1733209422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/322598-fusobacterium-nucleatum-induced-empyema-masquerading-as-lung-cancer-a-diagnostic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.75003","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}